Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers.

Tulassay Z, Stolte M, Engstrand L, Butruk E, Malfertheiner P, Dítê P, Tchernev K, Wong BC, Gottlow M, Eklund S, Wrangstadh M, Herszényi L, Nagy P; HELIX Study Investigators.

Scand J Gastroenterol. 2010 Sep;45(9):1048-58. doi: 10.3109/00365520903575737.

PMID:
20509752
2.

Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients.

Tulassay Z, Stolte M, Sjölund M, Engstrand L, Butruk E, Malfertheiner P, Dite P, Tchernev K, Wong BC, Gottlow M, Eklund S, Wrangstadh M, Nagy P.

Eur J Gastroenterol Hepatol. 2008 Jun;20(6):526-36. doi: 10.1097/MEG.0b013e3282f427ac.

PMID:
18467912
3.

Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme.

Malfertheiner P, Dent J, Zeijlon L, Sipponen P, Veldhuyzen Van Zanten SJ, Burman CF, Lind T, Wrangstadh M, BayerdOrffer E, Lonovics J.

Aliment Pharmacol Ther. 2002 Aug;16(8):1431-42.

4.

One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease.

Tulassay Z, Kryszewski A, Dite P, Kleczkowski D, Rudzinski J, Bartuzi Z, Hasselgren G, Larkö A, Wrangstadh M.

Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1457-65.

PMID:
11742194
5.

Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients.

Neville PM, Barrowclough S, Crocombe W, Axon AT, Wrangstadh M, Moayyedi P.

Dig Liver Dis. 2001 Mar;33(2):131-4. Erratum in: Dig Liver Dis 2001 May;33(4):392.

PMID:
11346140
6.

One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease.

Veldhuyzen Van Zanten S, Lauritsen K, Delchier JC, Labenz J, De Argila CM, Lind T, Treichel HC, Stubberöd A, Cockeram A, Hasselgren G, Göthe L, Wrangstadh M, Sinclair P.

Aliment Pharmacol Ther. 2000 Dec;14(12):1605-11.

7.

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study.

Mégraud F, Lehn N, Lind T, Bayerdörffer E, O'Morain C, Spiller R, Unge P, van Zanten SV, Wrangstadh M, Burman CF.

Antimicrob Agents Chemother. 1999 Nov;43(11):2747-52.

8.

The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.

Zanten SJ, Bradette M, Farley A, Leddin D, Lind T, Unge P, Bayerdörffer E, Spiller RC, O'Morain C, Sipponen P, Wrangstadh M, Zeijlon L, Sinclair P.

Aliment Pharmacol Ther. 1999 Mar;13(3):289-95.

9.

The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.

Lind T, Mégraud F, Unge P, Bayerdörffer E, O'morain C, Spiller R, Veldhuyzen Van Zanten S, Bardhan KD, Hellblom M, Wrangstadh M, Zeijlon L, Cederberg C.

Gastroenterology. 1999 Feb;116(2):248-53.

PMID:
9922303
10.

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.

Lind T, Veldhuyzen van Zanten S, Unge P, Spiller R, Bayerdörffer E, O'Morain C, Bardhan KD, Bradette M, Chiba N, Wrangstadh M, Cederberg C, Idström JP.

Helicobacter. 1996 Sep;1(3):138-44.

PMID:
9398894
11.

Dose-response of omeprazole combined with amoxycillin on duodenal ulcer healing and eradication of Helicobacter pylori.

Pommerien W, Schultze V, Braden B, Lembcke B, Wrangstadh M, Londong W.

Aliment Pharmacol Ther. 1996 Jun;10(3):303-8.

PMID:
8791955
12.

Pharmacokinetic and pharmacodynamic interactions between omeprazole and amoxycillin in Helicobacter pylori-positive healthy subjects.

Pommerien W, Braun M, Idström JP, Wrangstadh M, Londong W.

Aliment Pharmacol Ther. 1996 Jun;10(3):295-301.

PMID:
8791954
13.

Starvation-specific formation of a peripheral exopolysaccharide by a marine Pseudomonas sp., strain S9.

Wrangstadh M, Szewzyk U, Ostling J, Kjelleberg S.

Appl Environ Microbiol. 1990 Jul;56(7):2065-72.

14.

Supplemental Content

Loading ...
Support Center